聚二氧环己酮埋线特定穴位治疗非特异性慢性颈痛的疗效与安全性:随机受试者-评估者盲法假埋线对照预试验方案
本研究为一项为期8周、两臂平行、随机、受试者与评估者盲法、假埋线对照的预试验,计划纳入50例非特异性慢性颈痛患者,比较在颈部14个固定穴位埋入聚二氧环己酮线的真实埋线针灸与去除线体的假埋线装置(均每周1次、共4次)的疗效与安全性。主要结局为基线至第6周(干预后2周)视觉模拟量表(VAS)评分的平均变化。
要点
- 真实埋线组在颈部14个固定穴位埋入聚二氧环己酮线,假埋线组使用去除线体的假装置。
- 两组均每周治疗1次、共4次,主要结局为基线至第6周VAS评分平均变化。
- 次要结局包括临床相关反应率、颈部功能障碍指数、压痛阈、焦虑抑郁量表、EQ-5D、患者总体印象变化、盲法测试及不良事件。
核心结论
- 该预试验结果将为评估聚二氧环己酮埋线针灸治疗非特异性慢性颈痛临床效果的大规模临床试验提供有价值的数据。
研究设计与样本
- 研究为8周、两臂平行、随机、受试者-评估者盲法、假埋线对照的预试验,计划纳入50例合格患者并随机分配至真实埋线组或假埋线组。
主要发现
- 原文未报告研究结果。
关键数值与推荐
- 真实埋线组在颈部14个固定穴位接受埋线治疗,假埋线组接受相同治疗但使用去除线体的假装置。
- 两组均每周治疗1次、共4次。
- 主要结局为基线至第6周(干预后2周)VAS评分平均变化。
- 临床相关反应定义为VAS下降≥15 mm或相对基线下降百分比≥30%和≥50%的患者数占总患者数的比例。
- 次要结局包括颈部功能障碍指数、压痛阈、医院焦虑抑郁量表、EuroQol五维问卷、患者总体印象变化、盲法测试及不良事件。
临床怎么用
- 该方案尚处于预试验阶段,结果未报告,暂不能提供临床实践推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to evaluate the efficacy and safety of thread-embedding acupuncture (TEA) with polydioxanone thread embedded at various acupoints, compared with sham TEA, for the treatment of non-specific chronic neck pain. METHODS/DESIGN: This study will be an 8-week-long, two-armed, parallel, randomized, subject-assessor-blinded, sham-controlled pilot trial. Fifty eligible patients will be randomly allocated into the real TEA group or the sham TEA group. The real TEA group will receive TEA treatment at 14 fixed acupoints in the neck region. The sham TEA group will receive the same treatment as the real TEA group, but with a sham device with the thread removed. Both groups will receive treatment once a week for a total of four sessions. The primary outcome will be the mean change in the visual analog scale (VAS) from baseline to week 6 (2 weeks post intervention). Clinical relevance (ratio of the number of patients with decreases on the VAS of ≥15 mm or with percentiles ≥ 30% and ≥ 50% relative to baseline to the total number of patients), Neck Disability Index, pressure pain threshold, the Hospital Anxiety and Depression Scale, EuroQol 5-Dimensions questionnaire, Patient Global Impression of Change, blinding test, and adverse events will be used to assess secondary outcomes. DISCUSSION: The results of this study will provide valuable data for a large-scale clinical trial to evaluate the clinical effects of polydioxanone TEA in the treatment of patients with non-specific chronic neck pain. TRIAL REGISTRATION: Clinical Research Information Service (CRIS), Republic of Korea, KCT0002452 . Registered on 6 September 2017.
引用
- Kim E, Kim HS, Jung SY, et al. Efficacy and safety of polydioxanone thread embedded at specific acupoints for non-specific chronic neck pain: a study protocol for a randomized, subject-assessor-blinded, sham-controlled pilot trial. Trials. 2018. PMID: 30522504. doi:10.1186/s13063-018-3058-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。